Tranexamic acid for percutaneous nephrolithotomy: an abridged Cochrane Review.
Brent ClevelandBrett NorlingHill WangVardhil GandhiCarrie L PriceMichael BorofskyVernon PaisPhilippe D ViolettePublished in: BJU international (2023)
Based on a body of evidence of 10 RCTs, we found that systemic TXA in PCNL may reduce blood transfusions, major surgical complications, and hospital LOS, as well as improve SFR; however, it may increase AE. These findings should inform urologists and their patients in making informed decisions about the use of TXA in the setting of PCNL.